henhaobio
Sign in

Acta Pharmacologica SinicaMolecular BiologyPeer-reviewed journal article

C Terminus of DJ-1 Determines Its Homodimerization, Deglycation Activity and Suppression of Ferroptosis

Jiang LiiD, Xiaobing CheniD, Qian WuiD, Haiying Zhu, Chengyong Du, Meidan YingiD, Qiaojun HeiD, Hong ZhuiD, Bo YangiD, Ji CaoiD

PDFDOIPreprint
Citations
29
FWCI
1.62
Field percentile
top 13%

Abstract

DJ-1 is a multi-functional protein related to cancer and autosomal early-onset Parkinson disease (PD). Besides the well-documented antioxidative stress activity, recent studies suggest that DJ-1 has the deglycation enzymatic activity and the anti-ferroptosis function. Although it has been demonstrated that DJ-1 forms the homodimerization, which dictates its antioxidative stress activity, the relationship between the dimeric structure and newly reported activities remains largely elusive. In this study, we find that the deletion mutation of the last 3 amino acids at C terminus of DJ-1 disrupts its homodimerization in both transfected and purified DJ-1 protein. Further study shows that hydrophobic L187 residue is of great importance for DJ-1 homodimerization. In addition, the ability in methylglyoxal detoxification is almost abolished in the mutation of deleting last 3 residues at C terminus ({Delta}C3) and point mutant L187E compared with wild type DJ-1 (DJ-1 WT). We also find that the suppression of ferroptosis is fully inhibited by {Delta}C3 and L187E while partially suppressed by V51C. Thus, our findings show that C terminus of DJ-1 is crucial for its homodimerization, deglycation activity and suppression of ferroptosis.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISGalardon '22Mazza '22Song '21Sánchez‐Lan '21Solana‐Manr '21Solana‐Manr '20
64% semantic matchBiochemistry
E. Galardon, N. Mathas, D. Padovani+3 more·bioRxiv·Nov 9, 2022